Metformin Use in Populations With CKD, CHF, or CLD – Annals of Internal Medicine -American College of Physicians

Conclusion: Metformin use in patients with moderate CKD, CHF, or CLD with hepatic impairment is associated with improvements in key clinical outcomes. Our findings support the recent changes in metformin labeling.

Source: Metformin Use in Populations With CKD, CHF, or CLD | Annals of Internal Medicine | American College of Physicians

Leave a comment